Delivery Order SPE2DB24D1201-SPE2DB25FJEBC
- Not listed
- The Defense Logistics Agency awarded a $14,113.92 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens with a completion date of September 3, 2025. This competitively awarded, firm fixed-price contract is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The point of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens valued at $7,129.50. This is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and no set-aside designation was used in the award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. As a competitively awarded contract, this order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Mounjaro 10 mg/0.5 mL pens, with a ceiling value of $11,775.62. This firm fixed-price delivery order was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, and represents a competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $2,360.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on July 25, 2025, with a completion date of July 28, 2025. This non-competitive delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the Department of Defense medical supply chain. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,088.36 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen medication on July 25, 2025, with completion targeted for July 28, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency (DLA) awarded a $1,360.45 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $1,360.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This contract was awarded competitively with no set-aside designation and has an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under a larger procurement vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $2,586.22 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL). This firm fixed-price delivery order is non-competitive and utilizes a competitively awarded indefinite delivery contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. As a major...
- The Defense Logistics Agency awarded a delivery order valued at $5,380.78 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price delivery order utilizes no set-aside designation and represents a competitive award under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the vendor's location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $9,379.27 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pens on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed price delivery order is issued without set-aside status, indicating competitive award based on open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJEBCDelivery Order
The Defense Logistics Agency awarded a $10,551.13 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL) with an ultimate completion date of September 3, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value transaction within the company's broader pharmaceutical distribution operations supporting federal medical procurement. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. As a major pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, AmerisourceBergen maintains a significant role in the DLA's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 9/2/25 |